Saturday 17 October 2026
Export PBH’s income statement to Excel — free account
Prestige Consumer Healthcare Inc.
PBH Healthcare Drug Manufacturers Specialty & Generic
Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025. In the quarter to June 2026, revenue grew 6.48%, EPS fell 36.5%, free cash flow fell 14.2% and total debt rose 100.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
49.92
0.72
+1.46%
Follow PBH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 9.12% | 10.22% | 10.31% | 11.29% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
4 | 5 | 5 | 7 | |
| 4.30% | 5.52% | 5.47% | 5.94% | ||
ROIC |
4.70% | 6.82% | 7.15% | 7.63% | |
Return on Tangible Assets |
37.38% | 44.03% | 44.19% | 46.07% | |
Average Days of Receivables |
61.89 | 64.34 | 62.99 | 65.41 | |
Free Cash Flow per Share |
4.96 | 5.09 | 5.58 | 5.21 | |
Free Cash Flow |
235.36 | 246.45 | 267.19 | 255.45 | |
Capital Expenditures |
(14.04) | (11.18) | (9.45) | (7.98) | |
| Other line items | |||||
Cash ROIC |
5.82% | 8.32% | 9.08% | 8.64% | |
Accounts Receivable Turnover |
6.21 | 5.64 | 6.17 | 6.13 | |
Accounts Payable Turnover |
17.39 | 23.64 | 15.51 | 13.34 | |
Inventory Turnover |
2.99 | 3.21 | 3.07 | 3.09 | |
Average Days of Payables |
26.20 | 16.87 | 32.37 | 31.39 | |
Days of Inventory on Hand |
135.22 | 117.79 | 123.29 | 119.04 | |
Tax Rate |
(0.27) | (0.26) | (0.30) | (0.30) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
25.32% | 24.36% | 23.91% | 23.26% | |
Share Based Compensation of Revenue |
1.01% | 1.00% | 0.99% | 0.99% | |
Interest Coverage |
6.30 | 7.31 | 7.74 | 7.82 | |
Operating CF/Net income |
1.45 | 1.35 | 1.48 | 1.31 | |
Depreciation/Fixed assets |
0.29 | 0.27 | 0.25 | 0.43 | |
Capex/Depreciation |
(0.41) | (0.34) | (0.30) | (0.26) | |
Revenue per Share |
23.28 | 22.47 | 23.05 | 22.65 | |
Operating CF per Share |
5.25 | 5.32 | 5.78 | 5.37 | |
Capex per Share |
(0.30) | (0.23) | (0.20) | (0.16) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates